Retraction notice to “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies” [Nanomedicine: Nanotechnology, Biology and Medicine 10/1 (2014) 225–234]

IF 4.2 2区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2024-10-19 DOI:10.1016/j.nano.2024.102793

Elisa Carenza MSc , Verónica Barceló , Anna Morancho MSc , Lisa Levander MSc , Cristina Boada , Anna Laromaine PhD , Anna Roig PhD , Joan Montaner MD, PhD , Anna Rosell PhD

引用次数: 0

查看原文本刊更多论文

用于神经修复疗法的磁化内皮祖细胞的体外血管生成性能和体内脑靶向》[Nanomedicine: Nanotechnology, Biology and Medicine 10/1 (2014) 225-234]的撤稿通知。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nanomedicine : nanotechnology, biology, and medicine 工程技术-纳米科技

CiteScore

11.10

自引率

0.00%

发文量

133

审稿时长

42 days

期刊介绍： The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.